Compare ICU & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICU | PIII |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9M | 13.5M |
| IPO Year | N/A | N/A |
| Metric | ICU | PIII |
|---|---|---|
| Price | $0.26 | $3.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.25 |
| AVG Volume (30 Days) | ★ 1.5M | 10.3K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $881,000.00 | ★ $1,444,952,000.00 |
| Revenue This Year | $691.85 | N/A |
| Revenue Next Year | $64.17 | $14.85 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1195.59 | N/A |
| 52 Week Low | $0.22 | $3.50 |
| 52 Week High | $3.07 | $14.50 |
| Indicator | ICU | PIII |
|---|---|---|
| Relative Strength Index (RSI) | 35.81 | 20.83 |
| Support Level | $0.22 | $3.51 |
| Resistance Level | $0.28 | $3.85 |
| Average True Range (ATR) | 0.03 | 0.25 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 25.29 | 5.18 |
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.